CONTACT Professor Dr Salomé LeibundGut-Landmann Group / / /
Facility
ETH Zürich Institute / University of Geneva / London Research Institute of Cancer Research UK / Swiss Federal Institute of Technology Zurich / University of Lausanne / London Research Institute / Cantonal Institute of Microbiology / Institute of Microbiology / /
IndustryTerm
travel activities / immunological tools / research / /
MedicalCondition
experimental candidiasis / Invasive candidiasis / cryptococcal meningitis / mycoses / infections / human and animal disease / fungal infections / autoimmune diseases / novel opportunistic and endemic mycoses / disease / common hospital-acquired infections / clinically relevant fungal infections / fungal disease / Rare Disease / immunosuppressive diseases / white nose syndrome / Endemic infections / diseases / AIDS / infectious diseases / fungal infection / infection / T cell deficiency / fungal and other microbial infections / human disease / serious infection / fungal diseases / tuberculosis / Superficial infections / /
MedicalTreatment
antibiotics / chemotherapy / surgery / gastrointestinal surgery / immunosuppression / /
Organization
Institute of Microbiology / University of Geneva / University of Lausanne / Swiss Federal Institute of Technology Zurich / Cantonal Institute of Microbiology / Gebert Rüf Stiftung Novartis Foundation / London Research Institute / Swiss National Science Foundation / /
The molecular and cellular events leading to the body’s defence against fungal pathogens are not well-known. Elucidating these mechanisms is the aim of Professor Dr Salomé LeibundGut-Landmann’s current research proj